UPDF AI

Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.

M. Movahedi,D. Bishop,22 Authors,J. Mathers

2015 · DOI: 10.1200/JCO.2014.58.9952
Journal of Clinical Oncology · 107 Citations

TLDR

Obesity is associated with substantially increased CRC risk in patients with LS, but this risk is abrogated in those taking aspirin, likely to benefit from obesity prevention and/or regular aspirin.